The tragic death of Nkanu, the young son of renowned author Chimamanda Ngozi Adichie, has sparked a heart-wrenching debate about patient safety in Nigeria’s healthcare system. But here’s where it gets controversial: pharmacists are now sounding the alarm over the use of propofol in his case, demanding a full investigation into what they call a “grave patient-safety failure.” This isn’t just a local issue—it’s a wake-up call that exposes deeper systemic flaws in healthcare governance.
In a bold statement, the Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN) has highlighted a serious deviation from international standards in pediatric anesthesia and medication safety. According to AHAPN National Chairman, Pharm. Elechi Oyim, the continuous administration of propofol as a sedative to a child under three years old directly contradicts global guidelines. And this is the part most people miss: propofol, when used in prolonged infusions in young children, is linked to Propofol Infusion Syndrome (PRIS), a life-threatening condition associated with severe metabolic acidosis, muscle breakdown, cardiac failure, and sudden death.
Oyim emphasized that leading global health bodies, including the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), and British anesthesia institutions, have repeatedly warned against such practices in pediatric intensive care. The FDA explicitly states that propofol is not approved for long-term sedation in children due to its fatal risks. Yet, in Nkanu’s case, these warnings appear to have been ignored.
Beyond the clinical implications, AHAPN argues that this tragedy reveals a systemic governance failure. Oyim pointed out that allowing clinicians to act as prescribers, administrators, and sole monitors of high-risk medications without independent oversight is a recipe for disaster. “Healthcare delivery, like justice, relies on checks and balances,” he stated. Here’s the controversial question: Is the routine exclusion of pharmacists from critical care decisions a mere oversight, or a dangerous systemic flaw?
Oyim lamented the marginalization of pharmacists in medication-related decisions, particularly in anesthesia and pediatric care. Clinical pharmacists, he explained, are trained to identify unsafe drug choices, monitor dosage and duration, and intervene early to prevent fatal outcomes. “Medication safety is a shared responsibility,” he stressed. “High-risk drugs like propofol should never be used without structured multidisciplinary oversight.”
AHAPN is now calling for a thorough, transparent, and independent investigation into Nkanu’s death, along with urgent reforms to strengthen multidisciplinary medication governance in Nigerian hospitals. Oyim warned that failing to enforce international safety standards not only endangers lives but also increases institutional and legal liability.
Expressing deep sympathy to Chimamanda and her family, Oyim concluded with a powerful call to action: “Healthcare must evolve from professional dominance to collaborative accountability. Anything less is not just a clinical failure—it’s an ethical breach and a governance lapse that puts lives at unacceptable risk.”
But here’s the bigger question: Can Nigeria’s healthcare system truly reform itself, or will it take more tragedies like Nkanu’s to spark real change? Share your thoughts in the comments—this is a conversation we can’t afford to ignore.
